RxDoctor Payments Data

del Rey, MD

Family Medicine · Merriam, KSNPI 1649224718

Payments from drug & device makers

$2,547in general payments, 2019–2025

Across 159 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$515
  • Novo Nordisk$437
  • Pfizer$259
  • Lilly USA, LLC$256
  • Abbott$173
  • AstraZeneca$138
  • plus $767 from 21 others

What the payments were for

  • Food & beverage$2,547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,547 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$88,128
Medicare patients
411
Services billed
1,862

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$107,152
JardianceEmpagliflozin64$70,879
EliquisApixaban67$57,992
MounjaroTirzepatide21$24,294
TrulicityDulaglutide15$22,000
RybelsusSemaglutide11$19,182
Breo ElliptaFluticasone/Vilanterol22$8,908
XareltoRivaroxaban16$8,901
Varenicline Tartrate25$6,971
Atorvastatin Calcium604$4,999
Gabapentin199$4,921
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$4,380
Albuterol Sulfate HfaAlbuterol Sulfate108$4,175
Omeprazole242$3,982
Incruse ElliptaUmeclidinium Bromide11$3,829

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$437$126,334113 claims
Boehringer IngelheimJardiance$70$70,87964 claims
PfizerEliquis, Paxlovid$259$60,85078 claims
Lilly USA, LLCMounjaro, Trulicity$256$46,29536 claims
GSKBreo Ellipta, Incruse Ellipta$39$12,73733 claims
Johnson & JohnsonXarelto$11$8,90116 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$3,441344 claims
AbbVieSynthroid$515$2,36727 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Merriam

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →